Watchlist Price Alert

Trevi Therapeutics Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

6.46

0.13 (1.97%)

At close: Jun 17, 2025, 10:29 AM

Trevi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-47.91M	-29.07M	-29.15M	-33.94M	-32.76M	-26.05M	-20.55M	-12.86M	-11.09M
Depreciation & Amortization	147K	123K	43K	50K	47K	39K	23K	4K	4K
Stock-Based Compensation	3.59M	2.25M	2.33M	2.54M	2.42M	1.13M	496K	205K	142.00
Other Working Capital	5.22M	-2.8M	-1.24M	678K	641K	799K	-634K	630K	-421K
Other Non-Cash Items	-907K	-1.17M	-162K	974K	227K	215K	2.3M	2.6M	2.45M
Deferred Income Tax	n/a	n/a	n/a	-82K	9K	n/a	n/a	1.35M	n/a
Change in Working Capital	6.83M	-3.85M	-1.23M	1.51M	1.06M	1.58M	-568K	722K	-1.49M
Operating Cash Flow	-38.26M	-31.71M	-28.18M	-28.95M	-29M	-23.09M	-18.29M	-7.97M	-11.19M
Capital Expenditures	-35K	-137K	-159K	n/a	-32K	-9K	-158K	-13K	n/a
Cash Acquisitions	n/a	n/a	-829K	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-98.46M	-9.93M	-126.22M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	75.6M	69.5M	19M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.37M	n/a	829K	n/a	-32K	-9K	n/a	n/a	n/a
Investing Cash Flow	-21.53M	59.43M	-107.37M	n/a	-32K	-9K	-158K	-13K	n/a
Debt Repayment	-126K	-9.41M	-5.83M	n/a	14M	n/a	-4.81M	-8.25M	8.6M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-1.53M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-2.24M	n/a	n/a	n/a
Other Financial Acitivies	n/a	-211K	11.73M	-408K	-415K	389K	-520K	52K	n/a
Financial Cash Flow	61.48M	-7.91M	111.31M	20.77M	16.72M	73.21K	3.63K	21.72M	8.6M
Net Cash Flow	1.7M	19.81M	-24.24M	-8.17M	-12.31M	50.11M	-14.82M	13.73M	-2.6M
Free Cash Flow	-38.29M	-31.85M	-28.33M	-28.95M	-29.03M	-23.1M	-18.45M	-7.99M	-11.19M